Literature DB >> 16679697

Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy.

Daisuke Suzuki1, Masao Toyoda, Naoyuki Yamamoto, Masaaki Miyauchi, Mayuko Katoh, Moritsugu Kimura, Mayumi Maruyama, Masashi Honma, Tomoya Umezono, Mitsunori Yagame.   

Abstract

OBJECTIVE: The receptor for advanced glycation end-products (RAGE) is one of several advanced glycation end-product (AGE)-specific cellular receptors. To evaluate the relationship between AGE and RAGE in renal tissues of diabetic nephropathy (DN), we examined the levels of expression of AGE protein and of RAGE mRNA. We also investigated the relationships among the degree of mesangial expansion and the expression of AGE and RAGE mRNA. PATIENTS AND METHODS: Renal biopsy tissues were obtained from 20 patients with DN. We performed immunohistochemical staining using monoclonal anti-AGE antibody and in situ hybridization using non-radioactive oligonucleotide RAGE probe on these tissues. We also examined five control renal samples. We evaluated the intensity of positive anti-AGE antibody staining and the percentage of cells positive for RAGE mRNA. We also measured the total glomerular area and mesangial area in glomeruli using an automatic image analyzer. We then calculated the percentage of mesangial area as a proportion of the total glomerular area (%Mes).
RESULTS: Anti-AGE antibody was detected in the expanded mesangial matrix in DN but not in control samples. RAGE mRNA expression was detected mainly in glomerular intrinsic cells, including glomerular mesangial and epithelial cells, in both DN and control. %Mes correlated significantly with both the intensity of anti-AGE antibody positive staining and the percentage of cells positive for RAGE mRNA.
CONCLUSIONS: Our findings suggest that both AGE and RAGE are associated with the development and progression of DN.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679697     DOI: 10.2169/internalmedicine.45.1557

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  15 in total

1.  Up-regulated expression of advanced glycation end-products and their receptor in the small intestine and colon of diabetic rats.

Authors:  Pengmin Chen; Jingbo Zhao; Hans Gregersen
Journal:  Dig Dis Sci       Date:  2011-11-06       Impact factor: 3.199

Review 2.  A novel improved therapy strategy for diabetic nephropathy: targeting AGEs.

Authors:  Xuemei Zhou; Bochu Wang; Liancai Zhu; Shilei Hao
Journal:  Organogenesis       Date:  2012-01-01       Impact factor: 2.500

Review 3.  Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  J Mol Med (Berl)       Date:  2009-02-03       Impact factor: 4.599

Review 4.  Advanced glycation end products, oxidative stress and diabetic nephropathy.

Authors:  Sho-Ichi Yamagishi; Takanori Matsui
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

5.  In vivo and in vitro effects of SREBP-1 on diabetic renal tubular lipid accumulation and RNAi-mediated gene silencing study.

Authors:  Hao Jun; Zhao Song; Wang Chen; Rong Zanhua; Shi Yonghong; Liu Shuxia; Duan Huijun
Journal:  Histochem Cell Biol       Date:  2008-12-02       Impact factor: 4.304

6.  Effects of puerarin on receptor for advanced glycation end products in nephridial tissue of streptozotocin-induced diabetic rats.

Authors:  Jian Guo Shen; Mei Fen Yao; Xiao Chan Chen; Yun Fei Feng; Yu Hong Ye; Zhong Hang Tong
Journal:  Mol Biol Rep       Date:  2009-01-06       Impact factor: 2.316

7.  The role of bone marrow derived-mesenchymal stem cells in attenuation of kidney function in rats with diabetic nephropathy.

Authors:  Mohamed Talaat Abdel Aziz; Mohamed Abdel Aziz Wassef; Hanan Hosni Ahmed; Laila Rashed; Soheir Mahfouz; Mayssa Ibrahim Aly; Rania Elsayed Hussein; Mai Abdelaziz
Journal:  Diabetol Metab Syndr       Date:  2014-03-09       Impact factor: 3.320

8.  Advanced glycation end-products regulate extracellular matrix-adipocyte metabolic crosstalk in diabetes.

Authors:  Clarissa Strieder-Barboza; Nicki A Baker; Carmen G Flesher; Monita Karmakar; Christopher K Neeley; Dominic Polsinelli; Justin B Dimick; Jonathan F Finks; Amir A Ghaferi; Oliver A Varban; Carey N Lumeng; Robert W O'Rourke
Journal:  Sci Rep       Date:  2019-12-24       Impact factor: 4.379

9.  Nephrin loss is reduced by grape seed proanthocyanidins in the experimental diabetic nephropathy rat model.

Authors:  Xianhua Li; Zhaoli Gao; Haiqing Gao; Baoying Li; Tao Peng; Bei Jiang; Xiangdong Yang; Zhao Hu
Journal:  Mol Med Rep       Date:  2017-10-19       Impact factor: 2.952

10.  Spatholobus suberectus Ameliorates Diabetes-Induced Renal Damage by Suppressing Advanced Glycation End Products in db/db Mice.

Authors:  Moon Ho Do; Jinyoung Hur; Jiwon Choi; Yoonsook Kim; Ho-Young Park; Sang Keun Ha
Journal:  Int J Mol Sci       Date:  2018-09-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.